Back

Akebia Therapeutics Quote, Financials, Valuation and Earnings

Master the Market: The Formula for a 96.3% Win Rate Revealed!

Act now!

Buy

AKBA
Akebia Therapeutics

Last Price:

1.40

Seasonality Move:

2.81%

7 Day Trial

ALL ACCESS PASS

$ 7

Election Shock on August 19th?

Click here now to see the evidence I've gathered.

Akebia Therapeutics Price Quote

$1.40

+0.01 (+0.72%)

(Updated: May 8, 2024 at 6:00 PM ET)

Akebia Therapeutics Key Stats

Buy

Akebia Therapeutics (AKBA) is a Buy

Day range:

$1.38 - $1.56

52-week range:

$0.78 - $2.48

Dividend yield:

P/E ratio:

0.00

P/S ratio:

1.34

P/B ratio:

Volume:

Avg. volume:

6.4M

1-year change:

27.52%

Market cap:

$291.3M

Revenue:

$194.6M

EPS:

$-0.28

How Much Does Akebia Therapeutics Make?

How Much Are Akebia Therapeutics's Sales Annually?
AKBA Revenues are $194.6M
How Much Profit Does Akebia Therapeutics's Make A Year?
AKBA net income is -$51.9M

Is Akebia Therapeutics Growing As A Company?

What Is Akebia Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.01%
What Is Akebia Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%

Akebia Therapeutics Stock Price Performance

Did Akebia Therapeutics Stock Go Up Last Month?
Akebia Therapeutics share price went down by -6.71% last month
Did AKBA's Share Price Rise Over The Last Year?
AKBA share price rose by 27.52% over the past 1 year

What Is Akebia Therapeutics 52-Week High & Low?

What Is Akebia Therapeutics’s 52-Week High Share Price?
Akebia Therapeutics has traded as high as $2.48 over the past 52 weeks
What Is Akebia Therapeutics’s 52-Week Low Share Price?
Akebia Therapeutics has traded as low as $0.78 over the past 52 weeks

Akebia Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Akebia Therapeutics?

How Much Debt Does Akebia Therapeutics Have?
Total long term debt quarterly is $34.7M
How Much Cash Does Akebia Therapeutics Have?
Cash and short term investments quarterly total is $42.9M
What Is Akebia Therapeutics’s Book Value Per Share?
Book value per share is -0.16

Is Akebia Therapeutics Cash Flow Positive?

What Is AKBA Cash Flow From Operations?
Cash flow from operations (TTM) is -$23.4M
What Is Akebia Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$25.2M
What Is Akebia Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $0

Akebia Therapeutics Return On Invested Capital

Is Management Doing A Good Job?
AKBA return on invested capital is -196.84%
What Is Akebia Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -18.8%
What Is AKBA Return On Equity?
ROE is a measure of profitability and is 0%

Akebia Therapeutics Earnings Date & Stock Price

What Is Akebia Therapeutics's Stock Price Today?
A single share of AKBA can be purchased today for 1.39
What Is Akebia Therapeutics’s Stock Symbol?
Akebia Therapeutics trades on the nasdaq under the ticker symbol: AKBA
When Is Akebia Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Akebia Therapeutics is scheduled on May 9, 2024
When Is AKBA's next ex-dividend date?
Akebia Therapeutics's next ex-dividend date is May 8, 2024
How To Buy Akebia Therapeutics Stock?
You can buy Akebia Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Akebia Therapeutics Competitors

Who Are Akebia Therapeutics's Competitors?
Below is a list of companies who compete with Akebia Therapeutics or are related in some way:
- Aquestive Therapeutics Inc (AQST)
- Ocugen Inc (OCGN)
- Protagonist Therapeutics Inc (PTGX)
- SELLAS Life Sciences Group Inc (SLS)
- Stoke Therapeutics Inc (STOK)

Akebia Therapeutics Dividend Yield